The present study was conducted to investigate novel methylated targets in colorectal cancer (CRC). enriched in tumor-associated signaling pathways, including cellular tumor antigen p53, cell cycle and NOD-like receptor (NLR) signaling pathway. A total of 2 silenced genes with abnormal methylation in CRC were identified, including FBLN2 and PPP1R14A. The reverse-overlapped DEGs were enriched in… Continue reading The present study was conducted to investigate novel methylated targets in